Newron Pharmaceuticals is a biopharmaceutical company with its focus on novel therapies for central nervous system diseases and pain. Currently, Phase III trials of safinamide are ongoing for the treatment of Parkinson’s disease, which Merck Serono has exclusive global rights … Continue reading →

GeoVax Labs is a biotechnology company focused on the development of vaccines for diseases caused by HIV. The company’s vaccines are unique in expressing virus-like particles displaying the trimeric membrane-bound form of the HIV-1 envelope glycoprotein. Presently in Phase I … Continue reading →

EpiCept is a specialty pharmaceutical company focused on developing and commercializing pharmaceutical products to treat pain and cancer. The company’s cancer product, Ceplene, has been approved in the European Union, and its balanced pipeline of three major clinical product candidates … Continue reading →

Alnylam Pharmaceuticals is a biopharmaceutical company engaged in developing novel therapeutics based on RNA interference (RNAi). The company is at the helm of translating RNAi into a new class of innovative medicines, with a core focus on RNAi therapeutics for … Continue reading →

Transcept Pharmaceuticals is a specialty pharmaceutical company engaged in developing and commercializing proprietary products that address important therapeutic needs in the field of neuroscience. Intermezzo (zolpidem tartrate) sublingual tablet C-IV is the company’s first FDA-approved product. Commercialization and development rights … Continue reading →

Aradigm is an emerging specialty pharmaceutical company engaged in developing and commercializing a portfolio of drugs delivered by inhalation for the treatment of severe respiratory diseases. The company’s product candidates address the treatment of bronchiectasis, cystic fibrosis, inhalation tularemia, anthrax … Continue reading →

Aastrom Biosciences is the leading developer of patient-specific, expanded multicellular therapies for treating severe, chronic cardiovascular diseases. The company’s proprietary cell-processing technology enables the manufacturing of ixmyelocel-T, which is a patent-specific multicellular therapy expanded from a patient’s own bone marrow … Continue reading →

DARA BioSciences is a specialty pharmaceutical company engaged in developing and commercializing oncology treatment and supportive care products. Through agreements with various entities, the company has comprehensive commercial coverage across the national oncology market. DARA is part of an integrated … Continue reading →

BioLineRx is a biopharmaceutical development company focused on building a portfolio of products to address unmet medical needs or offer advantages over currently available therapies. The company’s portfolio presently consists of six clinical stage candidates, in addition to products in … Continue reading →